Development of allergic rhinitis in early life: A prospective cohort study in high-risk infants

Sawako Masuda1, Mizuho Nagao2, Satoko Usui1

  • 1Department of Otorhinolaryngology and Allergy Center, National Hospital Organization Mie National Hospital, Tsu, Japan.

Insights

Allergic rhinitis (AR) in infants with eczema or food allergies often develops into a wheezing condition. Early detection of AR-like symptoms in infancy is crucial for identifying children at high risk for recurrent wheeze.

Area of Science:

  • Pediatric Allergy and Immunology
  • Respiratory Medicine
  • Clinical Pediatrics

Background:

  • Allergic rhinitis (AR) is a prevalent childhood allergic disease, yet its early developmental process remains unclear.
  • Understanding AR development in early childhood is crucial for timely intervention.
  • This study investigates AR development, nasal cytology, and sensitization in relation to recurrent wheeze in high-risk infants.

Purpose of the Study:

  • To prospectively investigate the development of allergic rhinitis (AR) in infants.
  • To examine the relationship between nasal symptoms, cytology, sensitization, and recurrent wheeze.
  • To identify AR-like phenotypes in early childhood and their association with high-risk recurrent wheeze.

Main Methods:

  • Recruited infants under 2 years with atopic dermatitis (AD) and/or food allergy (FA) symptoms for a 2-year prospective follow-up.
  • Classified perennial AR phenotype based on persistent nasal symptoms, nasal eosinophils, and house dust mite (HDM) sensitization.
  • Utilized Cox proportional hazards regression to analyze associations with high-risk recurrent wheeze, adjusting for covariates.

Main Results:

  • Prevalence of nasal eosinophilia increased from 18.5% to 69.9% and HDM sensitization from 30.6% to 74.8% over 2 years.
  • AR-like phenotypes rose from 18.4% to 65.0% in the study cohort.
  • The AR-like phenotype at 2 years was significantly associated with the development of high-risk recurrent wheeze (HR 2.062).

Conclusions:

  • An HDM-related AR-like phenotype significantly increased during infancy in infants with AD/FA.
  • The development of an AR-like phenotype in infancy is a predictor of high-risk recurrent wheeze.
  • Early identification of AR-like phenotypes in at-risk infants is vital for managing and preventing recurrent wheeze.
Abstract

Related Concept Videos

Allergic Reactions02:06

Allergic Reactions

Overview
29.1K
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.8K
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
482
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
797
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
641
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
3.2K